| dbo:abstract |
NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics. Meningococcal meningitis is a bacterial infection caused by the bacterium Neisseria meningitidis, also known as meningococcus. The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup of Neisseria meningitidis in bioreactors. After fermentation, the polysaccharides are purified, formulated, and lyophilized using preservatives and stabilizers to make a vaccine product. The vaccine cannot protect from other serogroups of N. meningitidis and cannot eliminate the chance of infection by these serogroups. (en) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Meningococcal_meningitis_A,C,Y,W-135_Vaccine.png?width=300 |
| dbo:wikiPageExternalLink |
http://www.clsi.org/source/orders/free/m21-a.pdf http://www.jn-vaccines.org/NmVacACYW_DT_Brochure.pdf http://www.jn-vaccines.org/JN_meningitis_trials_in_West_Africa.htm http://www.jn-vaccines.org/NmVac4.pdf |
| dbo:wikiPageID |
20547586 (xsd:integer) |
| dbo:wikiPageLength |
22944 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1101519541 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Epidemic dbr:NMR dbr:Developing_countries dbc:Subunit_vaccines dbr:Vaccine dbr:Complement_deficiency dbr:Complement_system dbr:Saline_(medicine) dbr:Ciprofloxacin dbc:Meningococcal_vaccines dbr:Ceftriaxone dbr:WHO dbr:Active_pharmaceutical_ingredient dbr:Bacterial_capsule dbr:Asplenia dbr:Lactose dbr:Bioreactor dbr:College_health dbr:JN-International_Medical_Corporation dbr:Phosphate dbr:Meningococcal_meningitis dbr:Antibodies dbr:Neisseria_meningitidis dbr:Sialic_acid dbr:Polysaccharide dbr:International_Conference_on_Harmonisat...tion_of_Pharmaceuticals_for_Human_Use dbr:Properdin_deficiency dbr:Umrah dbr:Serogroup dbr:Rifampin dbr:Lyophilized dbr:CD4+_T_cell |
| dbp:atcPrefix |
J07 (en) |
| dbp:atcSuffix |
AH04 (en) |
| dbp:chemspiderid |
none (en) |
| dbp:pregnancyUs |
C (en) |
| dbp:routesOfAdministration |
Intramuscular (en) |
| dbp:target |
Neisseria meningitidis A,C,Y,W-135 (en) |
| dbp:type |
vaccine (en) |
| dbp:vaccineType |
polysaccharide (en) |
| dbp:verifiedfields |
changed (en) |
| dbp:verifiedrevid |
444518343 (xsd:integer) |
| dbp:width |
50 (xsd:integer) |
| dbp:wikiPageUsesTemplate |
dbt:Drugbox dbt:Reflist dbt:Short_description dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Vaccines |
| dcterms:subject |
dbc:Subunit_vaccines dbc:Meningococcal_vaccines |
| gold:hypernym |
dbr:Name |
| rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:WikicatMeningococcalVaccines dbo:Vaccine yago:Antigen115037339 yago:Immunogen103562739 yago:Matter100020827 yago:PhysicalEntity100001930 dbo:Drug yago:Substance100020090 yago:Vaccine104517535 umbel-rc:DrugProduct |
| rdfs:comment |
NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics. (en) |
| rdfs:label |
NmVac4-A/C/Y/W-135 (en) |
| owl:sameAs |
freebase:NmVac4-A/C/Y/W-135 yago-res:NmVac4-A/C/Y/W-135 wikidata:NmVac4-A/C/Y/W-135 https://global.dbpedia.org/id/4sjRJ |
| prov:wasDerivedFrom |
wikipedia-en:NmVac4-A/C/Y/W-135?oldid=1101519541&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/MenA.jpg wiki-commons:Special:FilePath/MenC.jpg wiki-commons:Special:FilePath/MenW135.jpg wiki-commons:Special:FilePath/MenY.jpg wiki-commons:Special:FilePath/Meningococcal_meningitis_A,C,Y,W-135_Vaccine.png |
| foaf:isPrimaryTopicOf |
wikipedia-en:NmVac4-A/C/Y/W-135 |
| is dbo:wikiPageRedirects of |
dbr:NmVac4-A/C/Y/W-135_-_DT dbr:NmVac4-A/C/Y/W-135_–_DT dbr:NmVac_A/C/Y/W-135 |
| is dbo:wikiPageWikiLink of |
dbr:Meningococcal_disease dbr:Pathogenic_bacteria dbr:Meningococcal_vaccine dbr:Neisseria_meningitidis dbr:NmVac4-A/C/Y/W-135_-_DT dbr:NmVac4-A/C/Y/W-135_–_DT dbr:NmVac_A/C/Y/W-135 |
| is foaf:primaryTopic of |
wikipedia-en:NmVac4-A/C/Y/W-135 |
